| Literature DB >> 33208581 |
Tomoyoshi Kuribara1, Yukinori Akiyama1, Takeshi Mikami1, Yusuke Kimura1, Katsuya Komatsu1, Rei Enatsu1, Yasuyuki Tokinaga2, Nobuhiro Mikuni1.
Abstract
Awake craniotomy has been widely performed in patients with glioma in eloquent areas to minimize postoperative brain dysfunction. However, neurological examination in awake craniotomy is sometimes problematic due to communication difficulties during the intraoperative awake period. We evaluated preoperative predictors of these difficulties in awake craniotomy for patients with glioma. In all, 136 patients with glioma who underwent awake craniotomy at our institution between January 2012 and January 2020 were retrospectively evaluated. Patients were divided into two groups (appropriately awake group and inappropriately awake group) depending on their state during the intraoperative awake period, and the relationship between communication difficulties in awake craniotomy and both clinical and radiological characteristics were assessed. The appropriately awake group included 110 patients, and the inappropriately awake group included 26 patients. Reasons for inclusion in the inappropriately awake group were insufficient wakefulness in 15 patients, restless state in 6, and intraoperative seizures in 5. In multivariate analysis, the likelihood of being inappropriately awake was inversely correlated with preoperative seizures (odds ratio [OR], 0.23; 95% confidence interval [CI], 0.06-0.89; p = 0.033) and positively correlated with left-sided lesions (OR, 7.31; 95% CI, 1.54-34.62; p = 0.012). Both lack of preoperative seizures and left-sided lesions were identified as risk factors for intraoperative difficulties in awake craniotomy for patients with glioma. Understanding these risk factors may lead to more appropriate determination of eligibility for awake craniotomy.Entities:
Keywords: awake craniotomy; glioma; insufficient wakefulness; intraoperative seizure; restless state
Year: 2020 PMID: 33208581 PMCID: PMC7812311 DOI: 10.2176/nmc.oa.2020-0232
Source DB: PubMed Journal: Neurol Med Chir (Tokyo) ISSN: 0470-8105 Impact factor: 1.742
Clinical characteristics of the appropriately and inappropriately awake groups
| Characteristics | Appropriately awake group | Inappropriately awake group | |
|---|---|---|---|
| Number, patients (%) | 110 (80.9) | 26 (19.1) | |
| Age, median (IQR), y | 53 (36–63) | 64 (50.8–77) | 0.007* |
| Sex, male (%) | 56 (50.9) | 16 (61.5) | 0.329 |
| Preoperative language impairment (%) | 14 (12.7) | 9 (34.6) | 0.012* |
| Preoperative seizure (%) | 48 (43.6) | 5 (19.2) | 0.022* |
| Past operation for this lesion (%) | 32 (29.1) | 5 (19.2) | 0.31 |
| Left-sided lesion (%) | 53 (48.2) | 22 (84.6) | <0.001* |
| Presence of multiple lesions (%) | 3 (2.7) | 2 (7.7) | 0.243 |
| Deep location (%) | 36 (32.7) | 7 (26.9) | 0.567 |
| Location of lesion | |||
| Frontal lobe (%) | 55 (50.0) | 11 (42.3) | 0.48 |
| Temporal lobe (%) | 23 (20.9) | 10 (38.5) | 0.06 |
| Others (%) | 32 (29.1) | 5 (19.2) | 0.31 |
| Lesion size, cm2 | 24.4 (12.3–41.5) | 33.5 (18.3–42.4) | 0.129 |
| Intraoperative posture | |||
| Supine (%) | 73 (66.4) | 20 (76.9) | 0.298 |
| Lateral (%) | 37 (33.6) | 6 (23.1) | |
| Anesthesia duration before IAP (min) | 261.5 (217.3–299.3) | 273.5 (239.3–304) | 0.34 |
| Intraoperative anticonvulsant | |||
| Phenytoin or fosphenytoin sodium (%) | 57 (51.8) | 14 (53.8) | 0.852 |
| Levetiracetam (%) | 53 (48.2) | 12 (46.2) | |
| Electrophysiological evaluation (%) | 91 (82.7) | 20 (76.9) | 0.332 |
| Pathological diagnoses | |||
| Oligodendroglioma (%) | 20 (18.2) | 7 (26.9) | 0.315 |
| Diffuse astrocytoma (%) | 18 (16.4) | 3 (11.5) | 0.394 |
| Anaplastic oligodendroglioma (%) | 13 (11.8) | 1 (3.8) | 0.205 |
| Anaplastic astrocytoma (%) | 14 (12.7) | 2 (7.7) | 0.372 |
| Glioblastoma (%) | 37 (33.6) | 12 (46.2) | 0.232 |
| Others (%) | 8 (7.3) | 1 (3.8) | 0.457 |
| High-grade glioma (%) | 66 (60.0) | 16 (61.5) | 0.885 |
| Genetic characterization | |||
| IDH-1 mutation (%) | 49 (45.4) | 10 (38.5) | 0.524 |
| p53 mutation (%) | 75 (69.4) | 18 (69.2) | 0.983 |
| Maximum BIS value (IQR) | 97 (94–98) | 96 (92–98) | 0.621 |
*p <0.05. BIS: bispectral index, IAP: intraoperative awake period, IQR: interquartile range.
Univariate and multivariate analyses for detecting inappropriately awake group in 136 patients
| Characteristics | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| Odds ratio (95% CI) | Odds ratio (95% CI) | |||
| Age | 1.04 (1.01–1.07) | 0.01* | ||
| Sex, male | 1.54 (0.64–3.70) | 0.331 | ||
| Preoperative language disorder | 3.63 (1.36–9.71) | 0.01* | ||
| Preoperative seizure | 0.31 (0.11–0.88) | 0.027* | 0.23 (0.06–0.89) | 0.033* |
| Past operation for this lesion | 0.58 (0.20–1.67) | 0.314 | ||
| Left-sided lesion | 7.89 (2.23–27.89) | 0.001* | 7.31 (1.54–34.62) | 0.012* |
| Presence of multiple lesions | 2.97 (0.47–18.77) | 0.247 | ||
| Deep location | 0.76 (0.29–1.97) | 0.568 | ||
| Location of lesion (frontal lobe/temporal lobe/other) | 0.97 (0.58–1.61) | 0.906 | ||
| Lesion size | 1.00 (1.00–1.00) | 0.238 | ||
| Intraoperative posture, lateral | 0.59 (0.22–1.60) | 0.301 | ||
| Anesthesia duration before intraoperative awake period | 1.00 (1.00–1.01) | 0.329 | ||
| Intraoperative anticonvulsant, LEV | 0.92 (0.39–2.17) | 0.852 | ||
| Electrophysiological evaluation | 0.70 (0.25–1.96) | 0.494 | ||
| High-grade glioma (grade 3, 4) | 1.07 (0.44–2.57) | 0.885 | ||
| GBM | 1.69 (0.71-4.02) | 0.235 | ||
| IDH-1 mutation | 0.75 (0.31–1.81) | 0.525 | ||
| p53 mutation | 0.99 (0.39–2.50) | 0.983 | ||
| Maximum BIS value | 0.97 (0.90–1.04) | 0.381 | ||
*p <0.05. CI: confidence interval, BIS: bispectral index, GBM: glioblastoma, LEV: levetiracetam.
Clinical characteristics of the appropriately awake group and subgroups of the inappropriately awake group
| Characteristics | Appropriately awake group | Insufficient wakefulness | Restlessness | Intraoperative seizure | |
|---|---|---|---|---|---|
| Number, patients (%) | 110 (80.9) | 15 (11.0) | 6 (4.4) | 5 (3.7) | |
| Age, median (IQR), y | 53 (36–63) | 67 (59–78) | 66.5 (45.5–77.5) | 45 (31.5–51.5) | 0.001* |
| Sex, male (%) | 56 (50.9) | 7 (46.7) | 5 (83.3) | 4 (80.0) | 0.257 |
| Preoperative language impairment (%) | 14 (12.7) | 4 (26.7) | 4 (66.7) | 1 (20.0) | 0.008* |
| Preoperative seizure (%) | 48 (43.6) | 2 (13.3) | 0 (0) | 3 (60.0) | 0.012* |
| Past operation for this lesion (%) | 32 (29.1) | 4 (26.7) | 1 (16.7) | 0 (0) | 0.681 |
| Left-sided lesion (%) | 53 (48.2) | 13 (86.7) | 5 (100.0) | 4 (80.0) | 0.001* |
| Presence of multiple lesions (%) | 3 (2.7) | 2 (13.3) | 0 (0) | 0 (0) | 0.243 |
| Deep location (%) | 36 (32.7) | 6 (40.0) | 1 (16.7) | 0 (0) | 0.416 |
| Location of lesion | |||||
| Frontal lobe (%) | 55 (50.0) | 5 (33.3) | 1 (16.7) | 5 (100.0) | 0.021* |
| Temporal lobe (%) | 23 (20.9) | 6 (40.0) | 4 (66.7) | 0 (0) | 0.020* |
| Other (%) | 32 (29.1) | 4 (26.7) | 1 (16.7) | 0 (0) | 0.681 |
| Lesion size, cm2 | 24.4 (12.3–41.5) | 29.2 (18.2–39.3) | 33.6 (19.9–43.3) | 41.3 (24.9–54.0) | 0.386 |
| Intraoperative posture | |||||
| Supine (%) | 73 (66.4) | 12 (80.0) | 3 (50.0) | 5 (0) | 0.233 |
| Lateral (%) | 37 (33.6) | 3 (20.0) | 3 (50.0) | 0 (0) | |
| Anesthesia duration before IAP (min) | 261.5 (217.3–299.3) | 276 (241–304) | 252 (217–277) | 288 (254–337) | 0.371 |
| Intraoperative anticonvulsant | |||||
| Phenytoin or fosphenytoin sodium (%) | 57 (51.8) | 10 (66.7) | 1 (16.7) | 3 (60.0) | 0.229 |
| Levetiracetam (%) | 53 (48.2) | 5 (33.3) | 5 (83.3) | 2 (40.0) | |
| Electrophysiological evaluation (%) | 91 (82.7) | 12 (80.0) | 4 (66.7) | 4 (80.0) | 0.641 |
| Pathological diagnoses | |||||
| Oligodendroglioma (%) | 20 (18.2) | 5 (33.3) | 0 (0) | 2 (40.0) | 0.182 |
| Diffuse astrocytoma (%) | 18 (16.4) | 0 (0) | 2 (33.3) | 1 (20.0) | 0.126 |
| Anaplastic oligodendroglioma (%) | 13 (11.8) | 0 (0) | 0 (0) | 1 (20.0) | 0.361 |
| Anaplastic astrocytoma (%) | 14 (12.7) | 2 (13.3) | 0 (0) | 0 (0) | 1.000 |
| Glioblastoma (%) | 37 (33.6) | 7 (46.7) | 4 (66.7) | 1 (20.0) | 0.292 |
| Others (%) | 8 (7.3) | 1 (6.7) | 0 (0) | 0 (0) | 1.000 |
| High-grade glioma (%) | 66 (60.0) | 10 (66.7) | 4 (66.7) | 2 (40.0) | 0.792 |
| Genetic characterizations | |||||
| IDH-1 mutation (%) | 49 (45.4) | 5 (33.3) | 1 (16.7) | 4 (80.0) | 0.169 |
| p53 mutation (%) | 75 (69.4) | 8 (53.3) | 6 (100.0) | 4 (80.0) | 0.201 |
| Maximum BIS values (IQR) | 97 (94–98) | 94 (87–97.5) | 96.5 (88.3–98) | 98 (92–98) | 0.612 |
*p <0.05. BIS: bispectral index, IQR: interquartile range, IAP: intraoperative awake period.
Univariate and multivariate analyses for detecting insufficient wakefulness in 136 patients
| Characteristics | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| Odds ratio (95% CI) | Odds ratio (95% CI) | |||
| Age | 1.07 (1.03–1.12) | 0.002* | ||
| Sex, male | 0.75 (0.26–2.21) | 0.607 | ||
| Preoperative language impairment | 1.95 (0.56–6.78) | 0.292 | ||
| Preoperative seizure | 0.21 (0.05–0.98) | 0.047* | 0.15 (0.02–1.23) | 0.077 |
| Past operation for this lesion | 0.97 (0.29–3.26) | 0.96 | ||
| Left-sided lesion | 6.08 (1.32–28.11) | 0.021* | ||
| Presence of multiple lesions | 6.05 (0.93–39.6) | 0.06 | ||
| Deep location | 1.51 (0.50–4.56) | 0.461 | ||
| Location of lesion (frontal lobe/temporal lobe/other) | 1.25 (0.67–2.34) | 0.477 | ||
| Lesion size | 1.00 (1.00–1.00) | 0.623 | ||
| Intraoperative posture, lateral | 0.51 (0.14–1.90) | 0.312 | ||
| Anesthesia duration before intraoperative awake period | 1.00 (0.99–1.01) | 0.426 | ||
| Intraoperative anticonvulsant, LEV | 0.51 (0.16–1.58) | 0.241 | ||
| Electrophysiological evaluation | 0.89 (0.23–3.42) | 0.864 | ||
| High-grade glioma (grade 3, 4) | 1.36 (0.44–4.23) | 0.594 | ||
| GBM | 1.65 (0.56-4.85) | 0.366 | ||
| IDH-1 mutation | 0.60 (0.19–1.87) | 0.38 | ||
| p53 mutation | 0.46 (0.15–1.36) | 0.159 | ||
| Maximum BIS value | 0.96 (0.88–1.05) | 0.374 | ||
*p <0.05. BIS: bispectral index, CIs: confidence interval, GBM: glioblastoma, LEV: levetiracetam.
Summary of patients with restlessness or intraoperative seizures
| Case No. | State | Age, y | Sex | POLD | POS | Past OH | Location of lesion | Lat. of lesion | Lesion mult. | Deep location | Lesion size, cm2 | IO Pos. | AD, min | IO AC | EE | PD | Maximum BIS value | IDH-1 mutation | p53 mutation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | R | 17 | M | (–) | (–) | (+) | Third ventricle | Midline | (–) | (+) | 7.6 | Supine | 341 | PHT | (+) | DA | 71 | (–) | (+) |
| 2 | R | 69 | M | (+) | (–) | (–) | Temporal | Left | (–) | (–) | 38.8 | Supine | 256 | LEV | (–) | GBM | 98 | (–) | (+) |
| 3 | R | 64 | F | (+) | (–) | (–) | Temporal | Left | (–) | (–) | 57.1 | Lateral | 179 | LEV | (+) | GBM | 95 | (–) | (+) |
| 4 | R | 82 | M | (+) | (–) | (–) | Frontal | Left | (–) | (–) | 34.6 | Supine | 230 | LEV | (+) | GBM | 98 | (–) | (+) |
| 5 | R | 76 | M | (+) | (–) | (–) | Temporal | Left | (–) | (–) | 32.7 | Lateral | 248 | LEV | (–) | GBM | 98 | (–) | (+) |
| 6 | R | 55 | M | (–) | (–) | (–) | Temporal | Left | (–) | (–) | 24 | Lateral | 256 | LEV | (+) | DA | 94 | (+) | (+) |
| 7 | I | 34 | M | (–) | (+) | (–) | Frontal | Left | (–) | (–) | 41.3 | Supine | 332 | PHT | (+) | AO | 98 | (+) | (+) |
| 8 | I | 51 | F | (–) | (–) | (–) | Frontal | Left | (–) | (–) | 62.1 | Supine | 288 | LEV | (+) | DA | 92 | (+) | (+) |
| 9 | I | 29 | M | (–) | (+) | (–) | Frontal | Left | (–) | (–) | 45.8 | Supine | 342 | LEV | (+) | OD | 98 | (+) | (+) |
| 10 | I | 52 | M | (+) | (–) | (–) | Frontal | Left | (–) | (–) | 36.4 | Supine | 273 | LEV | (+) | GBM | NA | (–) | (+) |
| 11 | I | 45 | M | (–) | (+) | (–) | Frontal | Right | (–) | (–) | 13.4 | Supine | 234 | PHT | (–) | OD | NA | (+) | (–) |
BIS: bispectral index, AC: anticonvulsant, AD: anesthetic duration before intraoperative awake period, AO: anaplastic oligodendroglioma, DA: diffuse astrocytoma, EE: electrophysiological evaluation, F: female, GBM: glioblastoma, I: intraoperative seizure, IO: intraoperative, Lat.: laterality, LD: language disorder, LEV: levetiracetam, M: male, NA: not available, OD: oligodendroglioma, OH: operation history, PD: pathological diagnosis, PHT: phenytoin or fosphenytoin sodium, PO: postoperative, Pos.: posture, R: restlessness, S: seizure.